APA 6th Edition Aufderheide, T.P. (2010). Clinical Trials. Signa vitae, 5 (Suppl. 1), 60-62. Preuzeto s https://hrcak.srce.hr/59440
MLA 8th Edition Aufderheide, Tom P.. "Clinical Trials." Signa vitae, vol. 5, br. Suppl. 1, 2010, str. 60-62. https://hrcak.srce.hr/59440. Citirano 05.04.2020.
Chicago 17th Edition Aufderheide, Tom P.. "Clinical Trials." Signa vitae 5, br. Suppl. 1 (2010): 60-62. https://hrcak.srce.hr/59440
Harvard Aufderheide, T.P. (2010). 'Clinical Trials', Signa vitae, 5(Suppl. 1), str. 60-62. Preuzeto s: https://hrcak.srce.hr/59440 (Datum pristupa: 05.04.2020.)
Vancouver Aufderheide TP. Clinical Trials. Signa vitae [Internet]. 2010 [pristupljeno 05.04.2020.];5(Suppl. 1):60-62. Dostupno na: https://hrcak.srce.hr/59440
IEEE T.P. Aufderheide, "Clinical Trials", Signa vitae, vol.5, br. Suppl. 1, str. 60-62, 2010. [Online]. Dostupno na: https://hrcak.srce.hr/59440. [Citirano: 05.04.2020.]
Sažetak The clinical practice of resuscitation science is dependent on discoveries generated in the basic science and animal
laboratory and then translated into clinical trials for application in humans. The successful implementation of prospective,
randomized, controlled, clinical trials in the field of cardiac arrest remains challenging and continues to evolve. Funding
for clinical trials of cardiac arrest is limited, and there are significant obstacles to performing such studies because of the
inability to obtain informed consent under these emergency circumstances. The absence of reliable national statistics on
cardiac arrest, evaluation of neurological outcome, and potential confounders such as post-resuscitation hospital-based
care and quality of cardiopulmonary resuscitation (CPR) continue to challenge cardiac arrest clinical trials. Nonetheless,
the immense public health burden of cardiac arrest is being recognized, appropriate public health initiatives to address the
problem are being implemented, and the resuscitation research community is meeting this challenge.